Is Transgene (EPA:TNG) Using Too Much Debt?
May 27
Have your own idea? Try our Stock Screener
French (CAC) Biotech Industry Analysis
UpdatedMay 31, 2025
DataAggregated Company Financials
Companies25
- 7D2.2%
- 3M-8.2%
- 1Y-34.8%
- YTDn/a
The Biotech is pretty flat in the last 7 days, but Sensorion has stood out, gaining 26%. As for the longer term, the industry has declined 35% in the last year. Looking forward, earnings are forecast to grow by 26% annually.
Industry Valuation and Performance
Has the French Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 01 Jun 2025 | €2.4b | €678.8m | -€675,383,201.68 | 16.5x | -3.5x | 3.5x |
| Tue, 29 Apr 2025 | €2.4b | €634.3m | -€569,139,784.61 | 26x | -4.2x | 3.8x |
| Thu, 27 Mar 2025 | €2.3b | €665.8m | -€495,483,287.57 | 15.3x | -4.6x | 3.4x |
| Sat, 22 Feb 2025 | €2.7b | €650.1m | -€526,247,602.95 | 17x | -5x | 4.1x |
| Mon, 20 Jan 2025 | €2.3b | €650.4m | -€528,311,549.27 | 17.9x | -4.3x | 3.5x |
| Wed, 18 Dec 2024 | €2.3b | €654.5m | -€548,665,233.54 | 17.9x | -4.2x | 3.5x |
| Fri, 15 Nov 2024 | €2.6b | €658.0m | -€545,638,741.26 | 17.4x | -4.8x | 4x |
| Sun, 13 Oct 2024 | €2.7b | €627.4m | -€511,194,935.39 | 19.6x | -5.3x | 4.3x |
| Tue, 10 Sep 2024 | €3.1b | €520.6m | -€580,691,075.97 | 37x | -5.3x | 5.9x |
| Thu, 08 Aug 2024 | €2.9b | €517.1m | -€591,773,047.71 | 37.2x | -4.9x | 5.6x |
| Sat, 06 Jul 2024 | €2.9b | €511.7m | -€566,770,513.45 | 26.2x | -5.1x | 5.7x |
| Mon, 03 Jun 2024 | €3.4b | €503.1m | -€564,341,760.72 | 27.2x | -6.1x | 6.8x |
| Wed, 01 May 2024 | €3.5b | €539.6m | -€701,693,804.50 | 27.3x | -4.9x | 6.4x |
| Fri, 29 Mar 2024 | €3.2b | €502.6m | -€565,573,818.70 | 21.8x | -5.6x | 6.3x |
| Sun, 25 Feb 2024 | €3.1b | €558.8m | -€674,250,189.65 | 21.7x | -4.5x | 5.5x |
| Tue, 23 Jan 2024 | €3.1b | €594.4m | -€684,318,062.00 | 22x | -4.5x | 5.2x |
| Thu, 21 Dec 2023 | €3.3b | €594.2m | -€682,905,461.00 | 22.8x | -4.8x | 5.5x |
| Sat, 18 Nov 2023 | €3.3b | €588.6m | -€671,826,120.00 | 21.9x | -4.9x | 5.6x |
| Mon, 16 Oct 2023 | €3.1b | €806.5m | -€616,906,757.00 | 21.1x | -5.1x | 3.9x |
| Wed, 13 Sep 2023 | €3.9b | €818.0m | -€728,141,503.00 | 23.8x | -5.3x | 4.7x |
| Fri, 11 Aug 2023 | €3.7b | €817.4m | -€723,887,443.00 | 24.5x | -5.1x | 4.5x |
| Sun, 09 Jul 2023 | €3.7b | €818.3m | -€736,211,706.00 | 24.9x | -5x | 4.5x |
| Tue, 06 Jun 2023 | €3.8b | €820.6m | -€744,799,931.00 | 25.3x | -5.1x | 4.7x |
| Thu, 04 May 2023 | €3.3b | €818.4m | -€784,615,860.00 | 29.2x | -4.3x | 4.1x |
| Sat, 01 Apr 2023 | €3.2b | €960.9m | -€692,018,559.00 | 16.5x | -4.6x | 3.3x |
| Mon, 27 Feb 2023 | €3.5b | €1.0b | -€459,287,867.00 | 10.2x | -7.6x | 3.4x |
| Wed, 25 Jan 2023 | €3.8b | €1.0b | -€455,273,376.00 | 12.6x | -8.3x | 3.6x |
| Fri, 23 Dec 2022 | €3.4b | €1.0b | -€456,758,455.00 | 12.7x | -7.5x | 3.3x |
| Sun, 20 Nov 2022 | €3.5b | €905.6m | -€698,054,826.00 | 15.7x | -5x | 3.9x |
| Tue, 18 Oct 2022 | €3.7b | €924.4m | -€707,124,885.00 | 29.8x | -5.2x | 4x |
| Thu, 15 Sep 2022 | €4.3b | €929.8m | -€761,919,475.00 | 118x | -5.6x | 4.6x |
| Sat, 13 Aug 2022 | €4.7b | €1.0b | -€746,866,644.00 | 120.6x | -6.3x | 4.6x |
| Mon, 11 Jul 2022 | €4.4b | €989.1m | -€687,154,315.00 | 122.9x | -6.4x | 4.5x |
| Wed, 08 Jun 2022 | €4.6b | €990.2m | -€689,507,312.00 | 135.4x | -6.7x | 4.7x |
Price to Earnings Ratio
-6.7x
Current Industry PE
- Investors are pessimistic on the French Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.5x is higher than the industry's current PS ratio of 3.5x.
Past Earnings Growth
- Losses for companies in the Biotechnology industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have declined 12% per year.
- This means that the cost of doing business could be reducing since sales have declined but losses haven't fallen much further.
Industry Comparison
How does French Biotech compare with similar industries?
| FR Market | 0.37% | |
| Healthcare | -2.24% | |
| Biotech | 2.22% | |
| Biotech | 2.22% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ALSEN Sensorion | €0.40 | 25.6% +€24.6m | -47.9% | PS18.2x | |
| IVA Inventiva | €2.89 | 4.9% +€18.8m | -12.7% | PS28.5x | |
| POXEL Poxel | €0.76 | 72.0% +€17.0m | 20.2% | PS18.5x | |
| NANO Nanobiotix | €3.67 | 9.4% +€14.9m | -43.5% | PE-2.6x | |
| ABVX ABIVAX Société Anonyme | €5.28 | 4.3% +€14.0m | -58.0% | PS31x |